patent/KR-20120010146-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120010146-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7254887bc4324c447a6a7cfda1e6b29c
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6811
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
filingDate	2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748660aec59c739297ffee80ef86ad91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b78471105cb13a7f89ee2d34bddafa8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ce52bb5fab5b037fad69d32110200f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37670e069c8eb6b5e563ba2bdeae8cb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08d06390094a90c67d3c192d955e4dc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7e4e39c187f3f0fd35d225239809c74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67ed582138dc5bb028fc302a4db3087
publicationDate	2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	KR-20120010146-A
titleOfInvention	Novel sustained glucagon conjugates and pharmaceutical compositions for the prevention and treatment of obesity comprising the same
abstract	The present invention relates to a novel sustained glucagon conjugate covalently linked to a polymer carrier by a non-peptide linker and a pharmaceutical composition for preventing and treating obesity comprising the same as an active ingredient. The sustained glucagon conjugate according to the present invention is improved in vivo sustainability and stability, significantly reducing the dose when co-administered with anti-obesity drugs while showing improved medication compliance without fluctuations in blood glucose, thereby preventing and treating obesity. It can be very useful.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10400020-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10696725-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11142559-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018004283-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981967-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370426-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667688-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135271-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11261227-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216129-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11332508-B2
priorityDate	2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409427228 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147943530

Total number of triples: 43.